BUY Recommendation: Gilead Sciences (GILD). Company Overview. Gilead Sciences, Inc. is a research-based biopharmaceutical company found in 1987 that discovers, develops and commercializes innovative medicines in areas of unmet medical need. . Current Portfolio. HIV vs Hepatitis. HIV Drug.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
-Stribild (QUAD): First HIV treatment regimen that combine drugs from the same company.
-4 in one pill
-#1 HIV regimen in the US
Gilead is the first pharmaceutical company to sign an agreement with the Medicines Patent Pool, which is working to increase global access to high-quality, low-cost antiretroviral therapy through the sharing of patents. The Patent Pool has been granted similar licensing terms for Gilead HIV medicines as our generic manufacturing partners.
Gilead has Medicines Patent Pool the right to develop and distribute its in 100 developing countries.
Analyst Opinion: 20 Buy, 2 hold, 0 sell
GILD’s nearest nine competitors averaged 54% buys
GILD vs S&P Biotechnology Index